Neutralization of human papillomavirus (HPV) pseudovirions: A novel and efficient approach to detect and characterize HPV neutralizing antibodies

Virology

Volumn 278, Issue 2, 2000, Pages 570-577

  Yeager, Mark D ^a   Aste Amezaga, Miguel ^a   Brown, Darron R ^b   Martin, Melissa M ^a   Shah, Mayur J ^a   Cook, James C ^a   Christensen, Neil D ^c   Ackerson, Chris ^a   Lowe, Robert S ^a   Smith, Judy F ^a   Keller, Paul ^a   Jansen, Kathrin U ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS VACCINE;

ANTIBODY DETECTION; ARTICLE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SCID MOUSE; TISSUE CULTURE; VIRION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WART VIRUS; XENOGRAFT;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 0034528632     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0674     Document Type: Article

References (37)

1. Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse
2. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
3. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
4. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: Correlation with virus-like particle IgG concentration
5. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies
6. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies
7. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes
8. Coinfection of human foreskin fragments with multiple human papillomavirus types (HPV-11, -40, and -LVX82/MM7) produces regionally separate HPV infections within the same athymic mouse xenograft
9. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11
10. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6
11. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae
12. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers
13. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
14. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
15. Sequence conservation within the major capsid protein of human papillomavirus (HPV) type 18 and formation of HPV-18 virus-like particles in Saccharomyces cerevisiae
16. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation
17. In vitro construction of pseudovirions of human papillomavirus type 16: Incorporation of plasmid DNA into reassembled L1/L2 capsids
18. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
19. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization
20. Epidemiology of genital human papillomavirus infection
21. Laboratory production in vivo of infectious human papillomavirus type 11
22. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: Characterization of protein domains involved in DNA binding and capsid assembly
23. Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast
24. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA
25. Papillomavirus capsid binding and uptake by cells from different tissues and species
26. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice
27. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae
28. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype
29. Expression of human papillomavirus type 11 L1 protein in insect cells: In vivo and in vitro assembly of viruslike particles
30. Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae
31. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe
32. In vitro gene transfer using human papillomavirus-like particles
33. Generation and neutralization of pseudovirions of human papillomavirus type 33
34. In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16
35. DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1
36. Expression of vaccinia recombinant HPV16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
37. Quantitation of transcription and clonal selection of single living cells with betalactamase as reporter